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Abstract
Aims/hypothesis The fluidity of cell membranes has been
hypothesised as an important link in the association of fatty
acids (FAs) with diabetes risk. The lipophilic index, which can
be derived from the FA profile of blood or tissues, has recently
been proposed as a novel measure of cell membrane FA
fluidity. In this study we aimed to evaluate the lipophilic index
in relation to the incidence of type 2 diabetes.
Methods We applied a nested case-cohort design (n=1,740,
including 362 cases) within the EPIC-Potsdam study, which
involves 27,548 middle-aged men and women. Erythrocyte
membrane FA proportions were measured at baseline and
physician-confirmed incident diabetes was assessed during a
mean follow-up of 7.0 years. The lipophilic index was calcu-
lated as the sum of the products of the FA proportions with the
respective FA melting points.
Results After multivariable adjustments, including body size
measures, there was a positive association between the lipo-
philic index and diabetes risk (HR comparing top with bottom
quartile 1.59 (95%CI 1.08, 2.34), p for trend across quartiles=
0.005). Adjustment for FAs, which are considered established
diabetes risk markers, did not substantially attenuate this
association.
Conclusions/interpretation A high lipophilic index,
reflecting lower membrane fluidity, may be associated
with a higher risk of type 2 diabetes. Our data corrob-
orate the hypothesis that membrane fluidity may be an
important mediator that links intake and metabolism of FAs to
diabetes risk.
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The fatty acid (FA) profile of blood and tissues integrates the
complex interplay between dietary intake of FAs and endog-
enous FA metabolism, and has been shown to be associated
with risk of type 2 diabetes in a number of studies [1–6]. As a
potential mechanism, there is a long-held view that the fluidity
of the cell membrane, which is importantly determined by its
FA composition, affects cellular functions [7]. Despite this
notion of an important role of membrane fluidity for diabetes
development, there is scarce data to support the relevance of
this hypothesis. In cell culture studies, it has been shown that
membrane fluidity affects glucose transport across mem-
branes as well as the properties of the insulin receptor
[8–10]. However, we are not aware of human studies investi-
gating the relevance of alterations of the fluidity of cell mem-
branes for the incidence of type 2 diabetes.
Membrane fluidity is strongly determined by the van der
Waals forces between FAs in the phospholipid bilayers. These
van der Waals forces are dependent on the chemical structure
of the FA molecules. The longer and straighter the FA chain,
the higher the van der Waals forces and the lower the FA
fluidity, as reflected by a high FA melting point. Consequent-
ly, long-chain saturated FAs (SFAs) with a straight FA chain
are characterised by a relatively high melting point, whereas
polyunsaturated fatty acids (PUFAs) with a high number of
double bonds, leading to a complex three-dimensional struc-
ture, generally have lower melting points.
Only recently, the lipophilic index has been proposed as a
measure of overall FA fluidity, which can be easily derived
from the FA composition of biological tissues. The lipophilic
index is characterised as the mean of the melting points of FAs
in biological tissues weighted by their specific concentrations
[11, 12]. Recent studies have suggested that a higher lipophilic
index in plasma and adipose tissue, reflecting decreased FA
fluidity, is associated with a higher risk of CHD [11, 12].
However, no significant association was observed for an
erythrocyte lipophilic index [11]. We are not aware of studies
that have related the lipophilic index to the incidence of type 2
diabetes.
In the current study, we aimed to investigate prospectively
the lipophilic index as a measure of the FA fluidity of eryth-
rocyte membranes in relation to the incidence of type 2
diabetes.
Methods
Study population The European Prospective Investigation in-
to Cancer and Nutrition (EPIC)-Potsdam study involves
27,548 participants (16,644 women aged mainly 35–65 years
and 10,904 men aged mainly 40–65 years) recruited from the
general population in Potsdam, Germany, between 1994 and
1998 [13]. Follow-up questionnaires have been administered
every 2–3 years to identify incident cases of type 2 diabetes
(response rates 91–96%). In the EPIC-Potsdam cohort, 849
cases of incident type 2 diabetes were identified during a mean
follow-up time of 7.0 years (see electronic supplementary
material [ESM] Methods for details on ascertainment of
type 2 diabetes). Consent was obtained from all participants.
Approval was given by the Ethical Committee of the State
Brandenburg, Germany.
A case-cohort study [14] within the prospective EPIC-
Potsdam study was designed. We randomly selected 2,500
individuals from all participants of the EPIC-Potsdam study
providing blood (n=26,444) for a subcohort, of which 1,406
remained after exclusion of participants with any history of
diabetes at baseline or with self-reported diabetes during
follow-up without physician confirmation (n=120), with
missing follow-up information (n=58), with FA concentra-
tions that were considered to be unreliable (n=598, see ESM
Methods for details), with missing or implausible biomarker
values (n=117, see ESMMethods for details) or with a history
of cardiovascular disease or cancer at baseline (n=201). We
excluded participants with a history of cardiovascular disease
or cancer since these participants may have changed their
habitual diet after diagnosis resulting in changed membrane
fluidity. Furthermore, it has been suggested that erythrocyte
membrane fluidity changes after an acute myocardial infarc-
tion event [15]. Of the 849 participants with incident diabetes
identified in the full cohort, 362 remained for analyses after
excluding cases with missing blood samples (n=48), with FA
concentrations that were considered to be unreliable (n=313,
see ESM Methods for details), with missing or implausible
biomarker values (n=36, see ESM Methods for details) or
with a history of cardiovascular disease or cancer at baseline
(n=90).
Measurement of FA composition in erythrocytes and calculation
of lipophilic index Peripheral venous blood samples were
taken at the baseline examination and were centrifuged at
1000 g for 10 min at 4°C. Plasma, erythrocytes and buffy coat
were removed and stored at −80°C. Erythrocyte membrane
FAs were measured between February and June 2008. A
detailed description of the laboratory methods can be found
in the ESMMethods. Briefly, FA methyl esters (FAME) were
separated on a GC-3900 gas chromatograph (Varian, Middel-
burg, the Netherlands) equipped with a 100 m×0.25 mm ID
WCOT-fused silica capillary column and flame ionisation
detector with separation of FAME peaks based on mixed
FAME standards (Sigma Aldrich, St Louis, MO, USA). The
FAs were expressed as the percentage of total FAs present in
the chromatogram.
The lipophilic index for the FA composition of the eryth-
rocyte membranes has been defined as a weighted mean of the
FAmelting points, as proposed in earlier publications [11, 12].
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More specifically, the index was calculated as the sum of the
products of the proportion (% of total FAs) with the melting
point (°C) of each individual FA, divided by the sum of the





proportion of FA %ð Þmelting point of FA Cð Þi½ 
X
κ
proportion of FA %ð Þi½ 
where i represents the individual FA, and k represents the
number of FAs used to calculate the lipophilic index.
Melting points of FAs were obtained from the LipidBank
database (http://lipidbank.jp/, accessed 19 November 2013) in
line with a previous publication on the lipophilic index and
risk of myocardial infarction [12]. Melting points were not
available in the LipidBank database for the following FAs:
16:1 n-9, 16:2 n-4, 16:3 n-4, 20:2 n-6, 20:3 n-6, 22:2 n-6 and
22:4 n-6. Hence, these FAs could not be considered in the
calculation of the lipophilic index (22% of measured FAs not
considered, 78% of measured FAs considered, for creating the
lipophilic index). Median proportions of the FAs without
information on the melting point in the erythrocyte
membranes were generally low in our subcohort (0.10% for
16:1 n-9, 0.03% for 16:2 n-4, 0.10% for 16:3 n-4, 0.25% for
20:2 n-6, 1.5% for 20:3 n-6, 0.05% for 22:2 n-6 and 2.7% for
22:4 n-6).
Measurement of further biomarkers Measurement of plasma
HDL-cholesterol, triacylglycerol, Gamma-glutamyl transfer-
ase (GGT), C-reactive protein (CRP), fetuin-A and random
glucose as well as HbA1c followed standard procedures [16].
Plasma total adiponectin concentrations were determined by
an ELISA (Linco Research, St Charles, MO, USA). All assays
were performed according to the manufacturer’s description.
Plasma biomarker values were multiplied with a sex-specific
correction factor of 1.16 for women and 1.17 for men to take
into account the plasma dilution caused by citrate addition
[17].
Other measurements We used baseline information on dietary
intake (assessed with a semi-quantitative food frequency ques-
tionnaire [FFQ]), education, smoking and physical activity
(assessed with a self-administered questionnaire and a personal
computer-guided interview) for our analyses. Details on the
assessment of these variables can be found in the ESMMethods.
Statistical analysis We performed Cox proportional hazards
analysis stratified by age to study the association between the
lipophilic index and the hazard of type 2 diabetes. Age was
used as the primary time-dependent variable in all models,
with entry time defined as the participant’s age at recruitment
and exit time as the date of diagnosis of diabetes (either type 2
diabetes [ICD10: E11; www.who.int/classifications/icd/en/]
or other types of diabetes mellitus [ICD10: E10, E13, E14]
because such participants were no longer at risk of developing
type 2 diabetes), death or return of the last follow-up ques-
tionnaire. To account for the case-cohort design, a weighted
Cox model was applied that was modified according to the
Prentice method [18]. We estimated HRs for quartiles of the
lipophilic index (quartiles were based on the subcohort distri-
bution) compared with the respective lowest quartile. The use
of quartiles was chosen to be able to account for non-linear
relationships with a sufficiently high number of incident cases
in each category. Cox regression models were first computed
with stratification for integers of age and adjustment for sex
(model 1), and then with further adjustment for sports activity
(0, 0.1–4.0, >4.0 h/week); biking (0, 0.1–2.4, 2.5–4.9,
≥5 h/week); smoking status (never, past, current <20 ciga-
rettes/day, current ≥20 cigarettes/day); education (in or no
training, vocational training, technical school or technical
college or university degree); alcohol intake (0, 0.1–5.0,
5.1–10.0, 10.1–20.0, 20.1–40.0, >40.0 g/day); total energy
intake (continuous); coffee intake (continuous); consumption
of sugar-sweetened beverages (continuous); dietary
PUFA/SFA ratio (continuous); protein intake (energy-adjusted
using residuals from linear regression [19]; continuous) and
carbohydrate intake (energy-adjusted using residuals from
linear regression [19]; continuous) (model 2). In a third model,
further adjustments were made for BMI and waist circumfer-
ence (both continuous). Categorical variables were entered as
binary indicator variables into the models. The significance of
linear trends across quartiles was tested by assigning each
participant the median value for the quartile and modelling
this value as a value of a continuous variable. A test for
statistical interaction of the lipophilic index with sex was
conducted by including a cross-product term in the model.
Multiple linear regression models were used to calculate
adjusted means of biomarkers for quartiles of the lipophilic
index in the subcohort, applying model 3 adjustments. Due to
differing biomarker distributions, these analyses were carried
out formen andwomen separately.We used geometricmeans for
biomarkers that were not normally distributed (triacylglycerol,
adiponectin, GGT, CRP, random glucose, HbA1c) and arithmetic
means if normal distribution was met (HDL-cholesterol,
fetuin-A).
We performed several sensitivity analyses to test the ro-
bustness of our findings. First, we excluded participants with
treated hypertension at baseline (n=389) because it has been
shown that membrane fluidity is altered in hypertension [20].
To investigate the possibility of reverse causation, we exclud-
ed participants with baseline HbA1c ≥6.5% (47.5 mmol/mol;
n=166) in a second sensitivity analysis and incident cases
diagnosed with diabetes within the first 2 years of follow-up
(n=81) in a third analysis. Fourth, we also investigated
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whether excluding participants in the unfasted state at blood
collection affects the association between the lipophilic index
and triacylglycerol levels (n=1,029). Fifth, we repeated analy-
ses without excluding participants with a history of cardiovas-
cular disease or cancer at baseline (n=275, leading to a final n
of 2,015 for analyses). For each of these sensitivity analyses,
model 3 adjustments were applied.
All statistical analyses were performed with SAS (version
9.2, Enterprise Guide 6.1; SAS Institute, Cary, NC, USA). All
statistical tests were two-sided and p values <0.05 were con-
sidered statistically significant.
Results
Median subcohort proportions of the individual erythrocyte
membrane FAs as well as Spearman correlation coefficients of
the individual FAs with the lipophilic index are presented in
Table 1. The highest proportions in erythrocyte membranes
were observed for 16:0 (22.3%), 18:0 (13.8%), 18:1 n-9
(12.7%), 20:4 n-6 (13.3%) and 18:2 n-6 (10.8%). As expected,
SFAs generally showed positive correlations with the lipophilic
index (exception: 18:0), whereas PUFAs were inversely corre-
lated with the index (exception: 18:3 n-6). Correlation coeffi-
cients for MUFAs and trans-FAs were usually close to zero.
Table 2 shows baseline characteristics of the subcohort
members by quartiles of the lipophilic index. Participants with
a high lipophilic index were more likely to be men and had a
slightly higher BMI compared with participants with a low
index, although this association did not reach statistical sig-
nificance. Leisure-time physical activity, smoking status and
educational attainment were not significantly associated with
the lipophilic index. With regard to dietary factors, a high
lipophilic index was associated with obtaining a slightly
higher proportion of energy from fat at the expense of protein
or carbohydrates.
HRs for the association of quartiles of the lipophilic index
with diabetes incidence are presented in Table 3. In the age- and
sex-controlled model (model 1), we observed a higher diabetes
risk when comparing top with bottom quartile of the lipophilic
index (HR 1.76 [95% CI 1.25, 2.47], p for trend <0.001). This
association slightly strengthened after further adjustment for
lifestyle factors, education and dietary factors (HR 1.85 [95%
CI 1.29, 2.65], p for trend <0.001). The HR was moderately
attenuated after further adjustment for BMI and waist circum-
ference (model 3), but still statistically significant (HR 1.59
[95% CI 1.08, 2.34], p=0.005). Additional adjustment for
diabetes-related FAs did not weaken this association (HR 1.90
[95% CI 1.25, 2.90], p<0.001). In our sensitivity analyses, the
exclusion of participants with treated hypertension at baseline,
baseline HbA1c ≥6.5% (47.5 mmol/mol) or incident cases
diagnosed with diabetes within the first 2 years of follow-up
did not materially change the results. The inclusion of partici-
pants with a history of cardiovascular disease or cancer at
baseline did moderately attenuate the HRs (HR comparing
top with bottom quartile 1.34 [95% CI 0.96, 1.87]), however,
there was still a significant positive trend across the quartiles
(p=0.02). The test for interaction of the lipophilic index with
sex was not significant (p=0.46).
In further analyses, we investigated whether the association
of the lipophilic index with diabetes risk could be explained
by individual FAs, for which a relation to diabetes risk has
already been shown. However, we did not observe a substan-
tial attenuation of the HR in our model 3 after additional
adjustment for proportions of 15:0 (HR comparing top with
bottom quartile of lipophilic index 1.77 [95% CI 1.18, 2.65]),
17:0 (HR 1.85 [95% CI 1.24, 2.76]), 18:0 (HR 1.59 [95% CI
1.08, 2.34]), 16:1 n-7 (HR 1.44 [95%CI 0.97, 2.13]), 18:2 n-6
(HR 1.58 [95% CI 1.07, 2.33]), 18:3 n-6 (HR 1.51 [95% CI
1.02, 2.23]), 20:3 n-6 (HR 1.81 [95% CI 1.22, 2.67]), or total
SFAs (HR 3.36 [95% CI 1.68, 6.75]), total trans-FAs
(HR 1.55 [95% CI 1.05, 2.30]), total MUFAs (HR 1.31 [95%
CI 0.79, 2.18]) and total PUFAs (HR 2.27 [95%CI 1.12, 4.60]).
ESM Figures 1 and 2 depict mean baseline biomarker
levels according to quartiles of the lipophilic index for men
and women of the subcohort. In general, we did not observe
strong associations of the lipophilic index with the bio-
markers. After multivariable adjustment, including body size
(model 3), there was a positive association of the lipophilic
index with fetuin-A in men (p for trend across quartiles
<0.001) and a slight positive association with HDL-
cholesterol in women (p=0.002). Baseline levels of triacyl-
glycerol, adiponectin, CRP and GGT showed no significant
trend across quartiles in both men and women. Excluding
participants with treated hypertension at baseline or with
baseline HbA1c ≥6.5% (47.5 mmol/mol) did not substantially
change these findings. Furthermore, the association between
the lipophilic index and triacylglycerol remained materially
unchanged after the exclusion of participants in the unfasted
state at blood collection (results not shown).
ESM Figures 3 and 4 show plasma random glucose and
HbA1c values by quartiles of the lipophilic index for men and
women of the subcohort. In women, we detected a positive
association of random glucose with the lipophilic index (p for
trend =0.01), whereas a slight inverse association was observed
for HbA1c (p for trend =0.01). In men, the positive association
of the lipophilic index with random glucose was only border-
line significant (p for trend =0.05) and the association with
HbA1c did not reach statistical significance (p for trend =0.08).
Discussion
In this prospective study of middle-aged men and women, a
high lipophilic index, indicating lesser fluidity of erythrocyte
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membranes, was associated with a higher risk of developing
type 2 diabetes after multivariable adjustments, including
body size.
The lipophilic index has been proposed recently as a mea-
sure of the FA fluidity of biological samples [11, 12]. It is
determined as the mean of the melting points of the individual
FAs weighted by their concentration, and hence can easily be
applied in large-scale epidemiological studies subject to the
availability of FA profile data in biological samples. In our
study, we were able to investigate the lipophilic index calcu-
lated from the FA profile of actual membranes, namely eryth-
rocyte membranes. Although the FA composition of erythro-
cyte membranes is not identical compared with other cells
important for glucose metabolism such as hepatocytes or
muscle cells, membranes of different cell types share a com-
mon feature, which lies in the exchange of phospholipids with
the plasma phospholipid pool. Nevertheless, it should be
noted that membrane fluidity is not only determined by its
FA composition, but also by other factors such as the choles-
terol content of the membrane, the degree of phospholipid
methylation and calcium binding [21–23].
To our knowledge, this is the first study that investigated
the lipophilic index as a measure of FA fluidity in relation to
type 2 diabetes risk. We observed a higher diabetes risk for
participants with a high lipophilic index reflecting lesser flu-
idity of the erythrocyte membranes. This finding is in line with
the long-held notion that membrane fluidity is an important
mediator that links intake and metabolism of FAs with diabe-
tes risk. In cell culture studies, it was shown that membrane
fluidity affects the glucose transport across membranes as well
as the properties of the insulin receptor [8–10], which is in
agreement with our findings.
Two earlier epidemiological studies have investigated the
lipophilic index in relation to myocardial infarction and CHD
[11, 12]. In a matched case–control study fromCosta Rica, the
lipophilic index for adipose tissue was significantly positively
Table 1 Melting points of FAs
and median proportions of
erythrocyte FAs, and correlation
coefficients of erythrocyte FAs
with lipophilic index for the
subcohort of the EPIC-Potsdam
study (n=1,406)














14:0 53.9 0.38 (0.30, 0.47) 0.34****
15:0 52.3 0.21 (0.17, 0.26) 0.27****
16:0 63.1 22.3 (21.2, 23.4) 0.49****
17:0 61.3 0.32 (0.29, 0.36) 0.16****
18:0 69.6 13.8 (12.8, 14.5) −0.09*
20:0 76.8 0.39 (0.34, 0.44) 0.50****
21:0 74.3 0.04 (0.03, 0.05) 0.22****
22:0 81.5 1.53 (1.32, 1.78) 0.62****
23:0 79.1 0.27 (0.23, 0.32) 0.36****
24:0 87.8 4.1 (3.5, 4.7) 0.70****
MUFAs
16:1 n-7 0 0.44 (0.35, 0.55) 0.16****
18:1 n-7 15.0 1.0 (0.9, 1.1) −0.08*
18:1 n-9 16.0 12.7 (12.0, 13.4) 0.08*
20:1 n-9 23.3 0.28 (0.25, 0.32) −0.13****
22:1 n-9 34.7 0.29 (0.21, 0.45) 0.08*
24:1 n-9 42.8 4.0 (3.5, 4.6) 0.59****
PUFAs
18:3 n-3 −11.2 0.15 (0.13, 0.18) −0.14****
20:5 n-3 −54.1 0.77 (0.61, 0.94) −0.40****
22:5 n-3 −54.1 2.4 (2.1, 2.6) −0.55****
22:6 n-3 −44.2 4.8 (4.1, 5.4) −0.62****
18:2 n-6 −5.0 10.8 (9.9, 11.7) −0.03
18:3 n-6 −11.2 0.05 (0.04, 0.07) 0.15****
20:4 n-6 −49.5 13.3 (12.3, 14.2) −0.71****
trans-FAs
16:1 n-7t 31.0 0.17 (0.14, 0.21) −0.08*
18:1 n-9t+18:1 n-7t 44.8 0.51 (0.44, 0.59) 0.12****
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associated with myocardial infarction in multivariable adjust-
ed models [12]. Similarly, the lipophilic index of plasma
phospholipids was significantly associated with a higher risk
of CHD in the Health Professionals Follow-up Study. The
erythrocyte lipophilic index, however, showed no significant
association with CHD risk in this study, although there was a
tendency towards a positive relation. The authors speculated
that higher measurement error for the FA measurements in
erythrocytes compared with plasma phospholipids in
their study may have led to an attenuation of the statistical
association [11].
In addition to the investigation of the biological meaning of
the lipophilic index, it is of interest whether the index is an
independent predictor of diabetes risk. After multivariable
adjustments, including body size measures, the effect size of
the association between lipophilic index and diabetes risk was
at least as strong in our study as those for a number of
individual FAs, which are considered as established diabetes
risk markers including 15:0, 17:0, 18:0, 18:2 n-6 and 20:3 n-6
(see our earlier publication [3] for details on results). Only
16:1 n-7 and 18:3 n-6 showed a somewhat stronger associa-
tion according to our earlier quintile analysis [3]. Of note,
adjustment for these FAs individually and simultaneously did
not lead to a substantial attenuation of the HR for the associ-
ation between the lipophilic index and diabetes risk, indicating
that the lipophilic index may provide predictive value beyond
individual FAs with regard to diabetes risk. Similarly, adjust-
ment for total SFAs, total trans-FAs and total PUFAs did not
lead to an attenuation of the HR between the lipophilic index
and diabetes risk, and adjustment for total MUFAs slightly
attenuated the HR likely reflecting that some MUFAs showed
associations with risk of diabetes (see our earlier publication
[3]). As expected, we have observed positive correlations of
individual SFAs and negative correlations of PUFAs with the
lipophilic index. Among those individual FAs with the
Table 2 Baseline characteristics by quartiles of the lipophilic index for
the subcohort of the EPIC-Potsdam study (n=1,406)
Quartile of lipophilic index p value
1 2 3 4
n (subcohort) 351 352 351 352
General characteristics
Age (years) 47.9 47.5 48.6 48.9 0.16
Men (%) 31.3 35.8 39.3 42.3 0.02
BMI (kg/m2) 25.1 25.2 25.5 25.6 0.13
WCa
Men 91.0 92.8 91.8 93.6 0.31
Women 78.0 78.0 78.5 78.0 0.43
Sport activities and
biking (h/week)
2.0 1.5 2.0 2.0 0.99
Never smokers (%) 49.9 45.7 45.3 46.3 0.45
College/university (%) 35.3 39.2 39.3 40.9 0.39
Dietary intake
Fat (% energy) 38.5 39.2 39.1 40.3 0.001
Carbohydrates (% energy) 42.2 42.6 42.7 41.2 0.05
Protein (% energy) 13.8 13.9 13.6 13.7 0.03
PUFA/SFA ratio 0.42 0.43 0.42 0.43 0.74
Alcohol (g/day) 9.2 8.6 8.9 9.2 0.82
Coffee (g/day) 302 302 450 450 0.16
Data are medians, unless otherwise indicated
aWC, waist circumference
Table 3 Risk of type 2 diabetes by quartiles of the lipophilic index in a case-cohort study embedded in the EPIC-Potsdam cohort (n=1,740)
Quartile of lipophilic index
1 2 3 4 p value
Median index 21.5 23.2 24.7 26.8
n (cases/ subcohort) 68/351 70/352 88/351 136/352




























Data are HRs (95% CI)
aModel 1 is stratified by age and adjusted for sex
bModel 2 is further adjusted for sports activity, biking, smoking status, education, alcohol consumption, total energy intake, coffee intake, sugar-
sweetened beverage intake, dietary PUFA/SFA ratio and intake of protein and carbohydrates (energy-adjusted)
cModel 3 is further adjusted for BMI and waist circumference
dDiabetes-related FAs: 15:0, 17:0, 18:0, 16:1 n-7, 18:2 n-6, 18:3 n-6, and 20:3 n-6
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strongest correlation with the lipophilic index, the long-chain
SFA 24:0 showed a strong positive association with diabetes
risk, whereas the PUFAs 20:5 n–3, 22:5 n–3 and 20:4 n–6
tended to be inversely associated with risk in our study,
although not significantly [3]. Interestingly, adjustment for
these individual FAs also did not attenuate the effect estimates
for the association of the lipophilic index with diabetes risk in
our study (results not shown), which further corroborates the
hypothesis that the lipophilic index is an independent predictor
of diabetes incidence.
We observed only very slight, if any, associations of our
lipophilic index with baseline levels of metabolic biomarkers.
Similar observations were made in the Health Professionals
Follow-up Study for the erythrocyte lipophilic index [11]. As
FA proportions and metabolic biomarkers have been assessed
in a cross-sectional manner (using baseline blood samples), it
was not possible to establish the correct time sequence (i.e. FA
proportions precede levels of metabolic markers) in this kind
of analysis. Still, clear positive cross-sectional associations of
the plasma and adipose tissue lipophilic index with triacyl-
glycerol have been detected in earlier studies, whereas less
consistent findings were obtained for inflammatory markers
[11, 12]. Surprisingly, we observed higher HDL-cholesterol
concentrations for women with a high lipophilic index, which
is counterintuitive. This finding is in contrast to earlier studies
that detected inverse associations of the plasma and dietary
lipophilic index with HDL-cholesterol [11, 12]. However, no
significant relations were seen for the erythrocyte and adipose
tissue lipophilic index in these studies [11, 12]. Given these
mixed findings, further studies should be performed to evalu-
ate this relationship, preferably with a prospective design.
Changed insulin sensitivity is a biological mechanism that
may link membrane fluidity to diabetes risk. Unfortunately,
we could not perform analyses with specific indicators of
insulin sensitivity, such as the HOMA index, owing to the
small number of fasted participants in our study. Instead, we
have performed analyses with other measures of glucose
metabolism, namely random glucose and HbA1c, which are,
however, not specific indicators of insulin sensitivity. The
results for the cross-sectional association of the lipophilic
index with random glucose and HbA1c were mixed. However,
when accounting for the correct time sequence in our prospec-
tive analyses, there was a relatively strong, significant, posi-
tive relationship between the lipophilic index and diabetes
incidence. This relationship turned out to be robust in various
sensitivity analyses, suggesting that changed membrane
fluidity is an important factor that precedes the development
of type 2 diabetes.
Our analysis has several limitations that should be
discussed. The lipophilic index is not a direct measurement
of cell membrane fluidity. Although the FA composition is a
strong determinant of membrane fluidity, other factors also
play a role [21–23]. Further studies using direct methods to
determine membrane fluidity are warranted to confirm our
findings. Furthermore, melting points of some FAs, especially
those with very low proportions in biological tissues (see
Methods), were not available in the LipidBank database and
hence could not be considered in the calculation of the lipo-
philic index. However, our results remained substantially the
same in a sensitivity analysis for which we excluded specific
FAs (proportion of less than 0.5% of total FAs) from the
lipophilic index (data not shown). We considered only clini-
cally apparent type 2 diabetes and did not screen our study
population for diabetes at baseline, thus it is possible that
prevalent but undiagnosed cases remained in our analyses.
Still, excluding participants with a baseline HbA1c higher than
6.5% (47.5 mmol/mol) or incident cases diagnosed with dia-
betes within the first 2 years of follow-up did not appreciably
change our results, suggesting that reverse causation should
not have had major effects on our findings. Further, we did not
screen participants for incident diabetes during follow-up.
However, all self-reports of diabetes during follow-up were
verified through the treating physician in our study. Given the
resulting high specificity and positive predictive value of the
disease classification, the remaining misclassification
(unidentified cases) should not have biased the estimated risk
[24]. Strengths of our study include the wide profile of FAs
(n=25 individual FAs) considered in the calculation of the
lipophilic index as well as the use of actual membranes to
reflect FA fluidity. The prospective design and high rate of
follow-up made reverse causation and bias through loss to
follow-up less likely. Comprehensive data on diet, lifestyle
and other risk factors allowed us to account for potential
confounders in detail.
In conclusion, our data suggest that a high lipophilic index
reflecting a lower fluidity of erythrocyte membranes is asso-
ciated with a higher risk of type 2 diabetes. Our findings
corroborate the hypothesis that membrane fluidity may be an
important mediator that links intake and metabolism of FAs to
diabetes risk. Hence, interventions aiming at an improvement
of cell membrane fluidity may have the potential to lower
diabetes risk. Our findings also suggest that the lipophilic
index is of value as an independent predictor of the incidence
of type 2 diabetes.
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